目的:采用AGREEⅡ工具评价我国已经发布的高血压病中医临床实践指南的质量。方法:采用手工检索与网络检索相结合的方法,检索国内已经公开发布的高血压病中医临床实践指南。采用AGREEⅡ工具进行评价,每个指南由3名评价者进行评价。分别分析每个指南的范围与目的、参与人员、制定的严谨性、清晰性与可读性、应用性、编辑独立性,最后进行指南的全面评估。结果:共纳入6个指南,评价结果表明,高血压病中医临床实践指南的清晰性与可读性质量最高,平均得分为60.2%;其次为编辑的独立性,平均得分52.9%;参与人员平均得分50.O%;制定的严谨性平均得分47.1%;范围和目的平均得分42.6%;应用性质量最低,平均得分37.8%。全面评估显示,强烈推荐使用的指南有2个,推荐(补充或改进)的指南有2个,2个指南不能确定是否推荐使用。结论:高血压病中医临床实践指南的应用性很低,在以后的指南研制中,要注重指南应用性质量的提高。
Objective: Using AGREE H instrument to evaluate the quality of the hypertensive TCM clinical practice guidelines (CPGs) which has been released in China. Methods: Using the method of manual search and network retrieval, search the hypertension TCM clinical practice guideline that has been published in China. The CPGs assessed by AGREE II instrument were included. Data in each CPG were analyzed in terms of six domains in the AGREE 1I instrument including scope and purpose, participants, conscientiousness, clarity, readability, applicability and editorial independence of CPGs. Results: There are 6 CPGs identified. All of the CPGs were included. The results showed that the quality of the clarity and readability was highest of all the CPGs. The average score was 60.2%. The editorial independence of CPGs was also good. The average score was 52.9%. The participants scored 50.0%. The conscientiousness of CPGs development scored 47.1%. The scope and purpose scored 42.6%. The applicability scored the lowest with only 37.8%. The general evaluation revealed that two CPGs were rated as 'strongly recommended', two as 'recommended with provision or aitemation', and two as 'unsure'. Conclusion: The quality of applicability is a significant shortcoming. Special attention should be paid to improve the quality of applicability in the development of hypertension TCM CPGs.